SCHEMBL4415224

SCHEMBL4415224

COc1cc2c(c(OC)c1)C(c1cccc(OC(F)(F)F)c1)N(C(=O)c1c(C)noc1C)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
GRIN2C Q14957 3/20 0.39
MTNR1B P49286 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
SCD5 Q86SK9 1/20 0.37
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MAPK7 Q13164 1/20 0.36
GFER P55789 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CYP2D6 P10635 1/20 0.35
FLT1 P17948 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423209 0.89 HTT (0.39) GRIN2CMTNR1BKMT2AMEN1SCD5
SCHEMBL4416972 0.85 GRIN2C (0.41) TSHRGRIN2CMTNR1BKMT2AMEN1
SCHEMBL4423047 0.84 GRIN2C (0.51) GRIN2CMTNR1BKMT2AMEN1LMNA
SCHEMBL4413447 0.83 KMT2A (0.55) GRIN2CKMT2AMEN1LMNANPSR1
SCHEMBL4416192 0.83 GRIN2C (0.47) GRIN2CMTNR1BKMT2AMEN1LMNA
SCHEMBL4418256 0.83 KMT2A (0.52) GRIN2CKMT2AMEN1LMNANPSR1
SCHEMBL6505108 0.83 GRIN2C (0.40) GRIN2CMTNR1BKMT2AMEN1LMNA
SCHEMBL4417027 0.83 MTNR1B (0.47) GRIN2CMTNR1BRAB9AKMT2AMEN1
SCHEMBL4418264 0.83 MTNR1B (0.52) TSHRGRIN2CMTNR1BKMT2AMEN1
SCHEMBL4413317 0.83 GRIN2C (0.43) GRIN2CMTNR1BKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663983-B1 N-SUBSTITUTED, 6,8-DIALKOXY-1,2,3,4-TETRAHYDRO-1H-ISOQUINOLINE AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2009-01-21 EP disclosed
US-20050070570-A1 Novel potassium channels modulators 4SC AG (DE) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070570-A1 Novel potassium channels modulators HCN4, KCNA4, KCNN4 TSHR 230/4885GRIN2C 567/4885MTNR1B 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.